Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence
- PMID: 17462022
- DOI: 10.1111/j.1365-2958.2007.05695.x
Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence
Abstract
The polysaccharidic capsule is the main virulence factor of Cryptococcus neoformans. It primarily comprised of two polysaccharides: glucuronoxylomannan (GXM, 88% of the capsule mass) and galactoxylomannan (GalXM, 7% of the capsule mass). We constructed a large collection of mutant strains in which genes potentially involved in capsule biosynthesis were deleted. We used a new post-genomic approach to study the virulence of the strains. Primers specific for unique tags associated with the disruption cassette were used in a real-time PCR virulence assay to measure the fungal burden of each strain in different organs of mice in multi-infection experiments. With this very sensitive assay, we identified a putative UDP-glucose epimerase (Uge1p) and a putative UDP-galactose transporter (Ugt1p) essential for C. neoformans virulence. The uge1Delta and ugt1Delta strains are temperature sensitive and do not produce GalXM but synthesize a larger capsule. These mutant strains (GalXM negative, GXM positive) are not able to colonize the brain even at the first day of infection whereas GXM-negative strains (GalXM positive) can still colonize the brain, although less efficiently than the wild-type strain.
Similar articles
-
Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.Cell Microbiol. 2008 Jun;10(6):1274-85. doi: 10.1111/j.1462-5822.2008.01125.x. Epub 2008 Jan 30. Cell Microbiol. 2008. PMID: 18284419
-
A new hexose transporter from Cryptococcus neoformans: molecular cloning and structural and functional characterization.Fungal Genet Biol. 2005 Jul;42(7):646-55. doi: 10.1016/j.fgb.2005.04.004. Fungal Genet Biol. 2005. PMID: 15907385
-
Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides.J Biol Chem. 2008 May 23;283(21):14327-34. doi: 10.1074/jbc.M708927200. Epub 2008 Mar 17. J Biol Chem. 2008. PMID: 18347023 Free PMC article.
-
Cryptococcus neoformans capsule biosynthesis and regulation.FEMS Yeast Res. 2004 Sep;4(8):765-71. doi: 10.1016/j.femsyr.2004.04.003. FEMS Yeast Res. 2004. PMID: 15450183 Review.
-
The capsule of the fungal pathogen Cryptococcus neoformans.Adv Appl Microbiol. 2009;68:133-216. doi: 10.1016/S0065-2164(09)01204-0. Adv Appl Microbiol. 2009. PMID: 19426855 Free PMC article. Review.
Cited by
-
Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis.Mol Microbiol. 2008 Jul;69(2):436-52. doi: 10.1111/j.1365-2958.2008.06290.x. Mol Microbiol. 2008. PMID: 18485073 Free PMC article.
-
Biology and function of exo-polysaccharides from human fungal pathogens.Curr Clin Microbiol Rep. 2020 Mar;7(1):1-11. doi: 10.1007/s40588-020-00137-5. Epub 2020 Jan 17. Curr Clin Microbiol Rep. 2020. PMID: 33042730 Free PMC article.
-
Toward an integrated model of capsule regulation in Cryptococcus neoformans.PLoS Pathog. 2011 Dec;7(12):e1002411. doi: 10.1371/journal.ppat.1002411. Epub 2011 Dec 8. PLoS Pathog. 2011. PMID: 22174677 Free PMC article.
-
Multiple GAL pathway gene clusters evolved independently and by different mechanisms in fungi.Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10136-41. doi: 10.1073/pnas.0914418107. Epub 2010 May 17. Proc Natl Acad Sci U S A. 2010. PMID: 20479238 Free PMC article.
-
Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection.Sci Rep. 2018 Nov 6;8(1):16378. doi: 10.1038/s41598-018-34649-4. Sci Rep. 2018. PMID: 30401972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources